Related Links

For an MP3 audio of the conference presentations email:
Oonagh Kelleher

» submit an item · an event

Addressing the big ‘Tissue Issues’ Professor Kevin Edge & RIS’s Dr Jenni Solbe
Addressing the big ‘Tissue Issues’ Professor Kevin Edge & RIS’s Dr Jenni Solbe
Photo by Nic Delves Broughton, University Photographer

Internal News - 10 February 2006

Tissue issues

Tissue regeneration - the rapidly developing science that offers patients new hope with its ability to repair damaged skin, bones and tissue structures - is set to transform healthcare over the next decade, delegates heard yesterday at a national conference held by the University of Bath’s Research & Innovation Service (RIS).

Over 120 delegates representing a dozen UK Universities, private companies and venture capitalists attended the event, ‘Tissue Regeneration: technologies, markets & commercial opportunities’, which was held in the City’s historic Guildhall.

In his opening address, Professor Kevin Edge, the University’s Pro Vice Chancellor for Research, highlighted the interdisciplinary nature of tissue regeneration, which involves biologists, chemical engineers and mechanical engineers. Bath’s own Centre for Regenerative Medicine provides an important focal point for this activity across departments.

Academics from the universities of Bath, Southampton and King’s College London gave presentations alongside speakers from the commercial sector representing key companies such as Smith and Nephew and Stryker Orthopaedics, and venture capital company, Avlar BioVentures.

For an MP3 audioof the conference presentations email Oonagh Kelleher.

Full Conference Agenda

Welcome: Dr Alison Evans, Technology Transfer, University of Bath
Chair’s Introduction: Dr John Hodgson

Session 1
Dr Andrew Jackson, Professor Christina Doyle (Director, XenoMedical) and Dr Cathy Prescott (Science Director, Avlar BioVentures)

Session 2
Dr Mike Manley (Chief Scientific Advisor, Stryker Orthopaedics), Professor Tony Miles (Centre for Orthopaedic Biomechanics, University of Bath) and Professor Richard Oreffo (School of Medicine, University of Southampton)

Session 3
Dr Penny Johnson (Director Research, UK, Intercytex), Dr Stephen Minger (Kings/London Regenerative Medicine Network) and Professor Jonathan Slack (Centre for Regenerative Medicine, University of Bath)

Session 4
Professor Sheila McNeil (CSO, Celltran) and Professor Julian Chaudhuri Centre for Regenerative Medicine (University of Bath)